SLC1A2 and Alzheimer disease: Based on the dysregulation of GLT1 in AD and the upregulating effect of sulbactam on GLT1, it may provide insights and clues for anti-AD research to study the improving effect of sulbactam on GLT1 and its neuronal protection in AD.